Menu Close

Anchored in Compliance: 340B Pearls for Covered Entities Webinar

| 12:00–1:00 p.m. CT
New: Pharmacy Continued Education (CE) Credit Available

Enroll >

If you manage 340B compliance across multiple sites and contract pharmacies, operational oversights created by disconnected systems and manual data pulls from incomplete or incorrect records can increase your audit exposure. Common Health Resources and Services Administration (HRSA) audit findings include dispensing 340B drugs to inpatients or from unregistered sites, out-of-date Office of Pharmacy Affairs Information System (OPAIS) registrations, patient definition misinterpretation and Medicaid Exclusion File errors. Teams also rely on manufacturers to price 340B drugs correctly, but overcharges can go unnoticed until a purchasing data review.

So, how can you avoid these program integrity pitfalls? Join us to explore the essentials of 340B compliance and why it's important to use the operational pearls and self-audit tools as your program anchors.

Objectives:

  • Understand key considerations for what qualifies as a covered outpatient drug (COD).
  • Recognize how the 340B price is calculated and made available to covered entities.
  • Identify operational practices that support compliant application of HRSA’s patient definition.

Speakers:

Michael Peters, PharmD, MBA, BCPS, 340B ACE

340B Compliance Director

Apexus

Sara Dwivedi, PharmD, MS, 340B ACE

340B Compliance Associate Director

Apexus

Experienced 340B subject matter experts will be available to answer your questions; registrants will receive a copy of the presentation slides afterward. The webinar will not be recorded.

Target Audience: Covered entities

Participant Knowledge Level: Intermediate

CE Credit: 1.0 contact hour (0.1 CEUs)

Event Date: Day, Month 00, 2026 | 12:00–1:00 p.m. CT

Enroll >

Continuing Education Information

Joint Accreditation Statement

Jointly Accredited Provider Interprofessional Continuing Education

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Apexus. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy Continuing Education
Partners designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

340B Prime Vendor Program (PVP) Tools

Sample HRSA 340B Audit Date Request List (DRL) for Covered Entities

This tool provides an example data request list (DRL) for a HRSA 340B audit. This is only a sample and may differ from an actual HRSA data request.